Isradipine, an L-type calcium channel blocker, attenuates cocaine effects in mice by reducing central glutamate release.
Autor: | Lima ALD; Department of Pharmacology, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Silva EG; Department of Immunology and Biochemistry, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Cardozo PL; Department of Immunology and Biochemistry, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., da Silva MCM; Department of Pharmacology, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Koerich S; Department of Pharmacology, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Ribeiro FM; Department of Immunology and Biochemistry, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Moreira FA; Department of Pharmacology, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Vieira LB; Department of Pharmacology, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. Electronic address: lubvieira@icb.ufmg.br. |
---|---|
Jazyk: | angličtina |
Zdroj: | European journal of pharmacology [Eur J Pharmacol] 2024 May 15; Vol. 971, pp. 176489. Date of Electronic Publication: 2024 Mar 15. |
DOI: | 10.1016/j.ejphar.2024.176489 |
Abstrakt: | Substance abuse disorder is a chronic condition for which pharmacological treatment options remain limited. L-type calcium channels (LTCC) have been implicated in drug-related plasticity and behavior. Specifically, dopaminergic neurons in the mesocorticolimbic pathway express Ca Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2024 Elsevier B.V. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |